1. Home
  2. IMAB vs MITK Comparison

IMAB vs MITK Comparison

Compare IMAB & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • MITK
  • Stock Information
  • Founded
  • IMAB 2014
  • MITK 1983
  • Country
  • IMAB United States
  • MITK United States
  • Employees
  • IMAB N/A
  • MITK N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • MITK Computer peripheral equipment
  • Sector
  • IMAB Health Care
  • MITK Technology
  • Exchange
  • IMAB Nasdaq
  • MITK Nasdaq
  • Market Cap
  • IMAB 384.6M
  • MITK 457.8M
  • IPO Year
  • IMAB 2020
  • MITK N/A
  • Fundamental
  • Price
  • IMAB $4.38
  • MITK $9.81
  • Analyst Decision
  • IMAB Strong Buy
  • MITK Strong Buy
  • Analyst Count
  • IMAB 4
  • MITK 3
  • Target Price
  • IMAB $6.75
  • MITK $12.17
  • AVG Volume (30 Days)
  • IMAB 2.1M
  • MITK 440.0K
  • Earning Date
  • IMAB 11-02-2025
  • MITK 08-07-2025
  • Dividend Yield
  • IMAB N/A
  • MITK N/A
  • EPS Growth
  • IMAB N/A
  • MITK N/A
  • EPS
  • IMAB N/A
  • MITK 0.33
  • Revenue
  • IMAB N/A
  • MITK $178,134,000.00
  • Revenue This Year
  • IMAB N/A
  • MITK $4.11
  • Revenue Next Year
  • IMAB N/A
  • MITK $7.57
  • P/E Ratio
  • IMAB N/A
  • MITK $29.38
  • Revenue Growth
  • IMAB N/A
  • MITK 6.98
  • 52 Week Low
  • IMAB $0.60
  • MITK $6.93
  • 52 Week High
  • IMAB $5.90
  • MITK $11.78
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 54.65
  • MITK 48.41
  • Support Level
  • IMAB $4.17
  • MITK $9.54
  • Resistance Level
  • IMAB $4.69
  • MITK $10.36
  • Average True Range (ATR)
  • IMAB 0.53
  • MITK 0.28
  • MACD
  • IMAB -0.12
  • MITK -0.07
  • Stochastic Oscillator
  • IMAB 25.44
  • MITK 22.50

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

Share on Social Networks: